گروه دارویی سبحان
دسبحا | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
Authorized
Last Price: 8,700 2.96
Close Price: 8,540
Cash Flow
AGM
Interim
2026/06/21 Fiscal Year 2026/03/2012 Month / Audited | 2026/06/10 Fiscal Year 2026/03/2012 Month | ||
|---|---|---|---|
Cash Generated from Operations | 1.573 Trillion | 17.004 Trillion | |
Income Taxes Paid | -1.471 Trillion | -1.471 Trillion | |
Net Cash Flow from Operating Activities | 1.573 Trillion | 15.533 Trillion | |
Proceeds from Sale of Property, Plant and Equipment | 3.157 Trillion | 3.157 Trillion | |
Purchases of Property, Plant and Equipment | -2.776 Trillion | -2.776 Trillion | |
Purchases of Intangible Assets | -77.924 Billion | -77.925 Billion | |
Proceeds from Sale of Investments in Associates | 5.769 Trillion | 5.774 Trillion | |
Cash Paid to Acquire Long-Term Investments | -485.855 Billion | -485.855 Billion | |
Proceeds from Sale of Short-Term Investments | 199.309 Billion | 199.309 Billion | |
Cash Received from Income on Other Investments | 105.692 Billion | 105.692 Billion | |
Net Cash Flow from Investing Activities | 380.264 Billion | -1.769 Trillion | |
Net Cash Flow before Financing Activities | 1.954 Trillion | 13.764 Trillion | |
دریافت های نقدی حاصل از افزايش سرمایه | 513.828 Billion | 513.828 Billion | |
Cash Received from Capital Increases of Subsidiaries | 975.005 Billion | 975.005 Billion | |
Proceeds from Sale of Treasury Shares | 230.419 Billion | 230.419 Billion | |
Purchases of Treasury Shares | -246.056 Billion | -1.725 Trillion | |
Cash Received from Borrowings | 1.43 Trillion | 82.303 Trillion | |
Repayments of Borrowings (Principal) | -1.256 Trillion | -61.118 Trillion | |
Interest Paid on Borrowings | -358.913 Billion | -18 Trillion | |
Dividends Paid | -1.204 Trillion | -1.204 Trillion | |
Dividends Paid to Non-Controlling Interests | -6.457 Trillion | -6.457 Trillion | |
Other Cash Flows from Financing Activities | -4.824 Trillion | -2.431 Trillion | |
Net Cash Flow from Financing Activities | -1.404 Trillion | -5.957 Trillion | |
Net Increase (Decrease) in Cash | 549.813 Billion | 7.808 Trillion | |
Cash at Beginning of Period | 36.15 Billion | 1.416 Trillion | |
Effect of Exchange Rate Changes | -286.142 Billion | 294.662 Billion | |
Cash at End of Period | 36.15 Billion | 36.15 Billion | |
Non-Cash Transactions | 10.44 Trillion | 24.471 Trillion |